Bone Marrow TransplantationTransplantation, HomologousBone MarrowGraft vs Host DiseaseHematopoietic Stem Cell TransplantationLeukemiaTransplantation, AutologousBone Marrow CellsTransplantation ConditioningLeukemia, Myeloid, AcuteLiver TransplantationWhole-Body IrradiationTransplantation ChimeraGraft SurvivalTissue DonorsKidney TransplantationPrecursor Cell Lymphoblastic Leukemia-LymphomaRecurrenceAnemia, AplasticTransplantation, IsogeneicBusulfanHistocompatibility TestingStem Cell TransplantationHistocompatibilityHematologic NeoplasmsAcute DiseaseTreatment OutcomeLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHematopoietic Stem CellsRemission InductionGraft RejectionHeart TransplantationImmunosuppressive AgentsCyclophosphamideTransplantation ImmunologyBone Marrow PurgingLung TransplantationCombined Modality TherapyBone and BonesLeukemia, MyeloidTime FactorsGraft vs Tumor EffectSurvival AnalysisRetrospective StudiesImmunosuppressionMice, Inbred C57BLLymphocyte DepletionHematopoiesisMyelodysplastic SyndromesOrgan TransplantationHepatic Veno-Occlusive DiseaseGraft vs Leukemia EffectBone Marrow DiseasesT-LymphocytesPeripheral Blood Stem Cell TransplantationRadiation ChimeraSurvival RateHLA AntigensCyclosporineLymphoma, Non-HodgkinLeukemia, LymphoidAntineoplastic Combined Chemotherapy ProtocolsCord Blood Stem Cell TransplantationLymphocyte TransfusionGraft vs Host ReactionMultiple MyelomaBone Marrow ExaminationDisease-Free SurvivalGranulocyte Colony-Stimulating FactorFollow-Up StudiesNuclear FamilyLeukemia, Biphenotypic, AcuteCytarabineLeukocyte TransfusionIslets of Langerhans TransplantationPancreas TransplantationMelphalanCell TransplantationAntigens, CD34Hematopoietic Stem Cell MobilizationTransplantationPrognosisLymphomaActuarial AnalysisChimeraHematologic DiseasesCytomegalovirus InfectionsColony-Forming Units AssayBone Marrow NeoplasmsMyeloablative AgonistsSevere Combined ImmunodeficiencyNeoplasm, ResidualSalvage TherapyMice, Inbred BALB CVidarabineCell DifferentiationImmunophenotypingHodgkin DiseaseTransplantation ToleranceLiving Donors